305 related articles for article (PubMed ID: 25384996)
61. Evaluating the use of optimally respiratory gated 18F-FDG-PET in target volume delineation and its influence on radiation doses to the organs at risk in non-small-cell lung cancer patients.
Wijsman R; Grootjans W; Troost EG; van der Heijden EH; Visser EP; de Geus-Oei LF; Bussink J
Nucl Med Commun; 2016 Jan; 37(1):66-73. PubMed ID: 26440570
[TBL] [Abstract][Full Text] [Related]
62. Geometrical differences in gross target volumes between 3DCT and 4DCT imaging in radiotherapy for non-small-cell lung cancer.
Li F; Li J; Zhang Y; Xu M; Shang D; Fan T; Liu T; Shao Q
J Radiat Res; 2013 Sep; 54(5):950-6. PubMed ID: 23564841
[TBL] [Abstract][Full Text] [Related]
63. Lung sparing in MR-guided non-adaptive SBRT treatment of peripheral lung tumors.
Lee HY; Lee G; Ferguson D; Hsu SH; Hu YH; Huynh E; Sudhyadhom A; Williams CL; Cagney DN; Fitzgerald KJ; Kann BH; Kozono D; Leeman JE; Mak RH; Han Z
Biomed Phys Eng Express; 2024 Jun; 10(4):. PubMed ID: 38861951
[No Abstract] [Full Text] [Related]
64. Evaluation of the organs at risk doses for lung tumors in gated and conventional radiotherapy.
Shahzadeh S; Gholami S; Aghamiri SMR; Mahani H; Nabavi M
J Cancer Res Ther; 2020; 16(4):726-730. PubMed ID: 32930110
[TBL] [Abstract][Full Text] [Related]
65. Magnitude of residual internal anatomy motion on heavy charged particle dose distribution in respiratory gated lung therapy.
Mori S; Asakura H; Kandatsu S; Kumagai M; Baba M; Endo M
Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):587-94. PubMed ID: 18474315
[TBL] [Abstract][Full Text] [Related]
66. Intra- and inter-fractional variations of tumors with fiducial markers measured using respiratory-correlated computed tomography images for respiratory gated lung stereotactic body radiation therapy.
Manabe Y; Shiinoki T; Fujimoto K; Ueda K; Karita M; Ono T; Kajima M; Tanaka H
J Appl Clin Med Phys; 2024 Jun; 25(6):e14280. PubMed ID: 38252745
[TBL] [Abstract][Full Text] [Related]
67. 4DMRI-based investigation on the interplay effect for pencil beam scanning proton therapy of pancreatic cancer patients.
Dolde K; Zhang Y; Chaudhri N; Dávid C; Kachelrieß M; Lomax AJ; Naumann P; Saito N; Weber DC; Pfaffenberger A
Radiat Oncol; 2019 Feb; 14(1):30. PubMed ID: 30732657
[TBL] [Abstract][Full Text] [Related]
68. CT-guided intracavitary radiotherapy for cervical cancer: Comparison of conventional point A plan with clinical target volume-based three-dimensional plan using dose-volume parameters.
Shin KH; Kim TH; Cho JK; Kim JY; Park SY; Park SY; Kim DY; Chie EK; Pyo HR; Cho KH
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):197-204. PubMed ID: 16169676
[TBL] [Abstract][Full Text] [Related]
69. Dosimetric comparison of liver tumour radiotherapy in all respiratory phases and in one phase using 4DCT.
Gabryś D; Kulik R; Trela K; Ślosarek K
Radiother Oncol; 2011 Sep; 100(3):360-4. PubMed ID: 21974916
[TBL] [Abstract][Full Text] [Related]
70. Evaluation and mitigation of the interplay effects of intensity modulated proton therapy for lung cancer in a clinical setting.
Kardar L; Li Y; Li X; Li H; Cao W; Chang JY; Liao L; Zhu RX; Sahoo N; Gillin M; Liao Z; Komaki R; Cox JD; Lim G; Zhang X
Pract Radiat Oncol; 2014; 4(6):e259-68. PubMed ID: 25407877
[TBL] [Abstract][Full Text] [Related]
71. Experimental validation of heterogeneity-corrected dose-volume prescription on respiratory-averaged CT images in stereotactic body radiotherapy for moving tumors.
Nakamura M; Miyabe Y; Matsuo Y; Kamomae T; Nakata M; Yano S; Sawada A; Mizowaki T; Hiraoka M
Med Dosim; 2012; 37(1):20-5. PubMed ID: 21497502
[TBL] [Abstract][Full Text] [Related]
72. Importance of protocol target definition on the ability to spare normal tissue: an IMRT and 3D-CRT planning comparison for intraorbital tumors.
Hein PA; Gladstone DJ; Bellerive MR; Hug EB
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1540-8. PubMed ID: 16029816
[TBL] [Abstract][Full Text] [Related]
73. Motion mitigation for lung cancer patients treated with active scanning proton therapy.
Grassberger C; Dowdell S; Sharp G; Paganetti H
Med Phys; 2015 May; 42(5):2462-9. PubMed ID: 25979039
[TBL] [Abstract][Full Text] [Related]
74. The use of respiratory-correlated four-dimensional CT where kidney motion has the potential to impact upon the radiotherapy planning process.
Gawthrop JB; Gill S
J Med Imaging Radiat Oncol; 2012 Dec; 56(6):689-95. PubMed ID: 23210590
[TBL] [Abstract][Full Text] [Related]
75. Evaluation of tumor position and PTV margins using image guidance and respiratory gating.
Nelson C; Balter P; Morice RC; Bucci K; Dong L; Tucker S; Vedam S; Chang JY; Starkschall G
Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1578-85. PubMed ID: 20137865
[TBL] [Abstract][Full Text] [Related]
76. Comparison of the dose on specific 3DCT images and the accumulated dose for cardiac structures in esophageal tumors radiotherapy: whether specific 3DCT images can be used for dose assessment?
Tong Y; Gong G; Su M; Yin Y
Radiat Oncol; 2019 Dec; 14(1):242. PubMed ID: 31881901
[TBL] [Abstract][Full Text] [Related]
77. Influence of technologic advances on outcomes in patients with unresectable, locally advanced non-small-cell lung cancer receiving concomitant chemoradiotherapy.
Liao ZX; Komaki RR; Thames HD; Liu HH; Tucker SL; Mohan R; Martel MK; Wei X; Yang K; Kim ES; Blumenschein G; Hong WK; Cox JD
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):775-81. PubMed ID: 19515503
[TBL] [Abstract][Full Text] [Related]
78. 4D VMAT, gated VMAT, and 3D VMAT for stereotactic body radiation therapy in lung.
Chin E; Loewen SK; Nichol A; Otto K
Phys Med Biol; 2013 Feb; 58(4):749-70. PubMed ID: 23324560
[TBL] [Abstract][Full Text] [Related]
79. Investigating the potential impact of four-dimensional computed tomography (4DCT) on toxicity, outcomes and dose escalation for radical lung cancer radiotherapy.
Cole AJ; O'Hare JM; McMahon SJ; McGarry CK; Butterworth KT; McAleese J; Jain S; Hounsell AR; Prise KM; Hanna GG; O'Sullivan JM
Clin Oncol (R Coll Radiol); 2014 Mar; 26(3):142-50. PubMed ID: 24332210
[TBL] [Abstract][Full Text] [Related]
80. [Dosimetric evaluation of intensity-modulated tangential beam versus conventional tangential irradiation for breast cancer].
Huang XB; Jiang GL; Chen JY; Chen LF; Hu WG
Ai Zheng; 2006 Jul; 25(7):855-60. PubMed ID: 16831277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
